4. On Liberty Australian Pharmaceutical CEO On Challenges During Covid-19

Centre for Independent Studies

English - May 13, 2020 01:39 - 43 minutes - 40.2 MB - ★★★★★ - 1 rating
News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 3. On Liberty 'Social' Interactions During Lockdown

Next Episode: 5. On Liberty Jacinta Price: Lockdown And Indigenous Communities

Our weekly live-stream hosted by Salvatore Babones, featuring discussions on how Australian society has been impacted by Covid-19. For your chance to question CIS researchers and other guests join us live on YouTube and Facebook each week.

On the show this week, Salvatore Babones speaks with James McBrayer, CEO of the listed medical technology company Cyclopharm and CIS Member. James's company is rare in that it still manufactures here in Australia. The local production line manufactures and distributes the components to several of its products including Technegas, a radio-pharmaceutical used in lung ventilation imaging.

We'll be asking James about how his company's products may help fight the coronavirus, the regulatory complexities in operating across jurisdictions and the impact of the variations among healthcare systems. James and Salvatore will also address the current challenges posed for medical supply chains with increased demand across the sector.

Watch to find out what it is like to run a multinational pharmaceutical company in the face of such global uncertainty